1. The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma

   • Hongfang Zhang
   • Jingxing Si
   • Shenglin Ma

   Review – Cancer Research 09 March 2021 Pages: 1275 - 1286

   

2. The tumor suppressor role of salvador family WW domain-containing protein 1 (SAV1): one of the key pieces of the tumor puzzle

   • Ísis Salviano Soares de Amorim
   • Mariana Moreno de Sousa Rodrigues
   • Andre Luiz Mencalha

   Review – Cancer Research 12 February 2021 Pages: 1287 - 1297

   

3. Bi-direction effects between microbiome and MiRNAs in carcinogenesis

   • Qinglin Wang
   • Hanlin Ding
   • Qixing Mao

   Review – Cancer Research 25 March 2021 Pages: 1299 - 1305

4. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer

   • Ciro Franzese
   • M. Badalamenti
   • M. Scorsetti

   Original Article – Cancer Research 20 January 2021 Pages: 1307 - 1313

   

5. HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma

   • Zimin Liu
   • Mingpeng Shi
   • Lu Zhang

   Original Article – Cancer Research Open access 04 February 2021 Pages: 1315 - 1324

   

6. Socioeconomic disparities in head and neck cancer survival in Germany: a causal mediation analysis using population-based cancer registry data

   • Ahmed Bedir
   • Semaw Ferede Abera
   • Daniel Medenwald

   Original Article – Cancer Research Open access 11 February 2021 Pages: 1325 - 1334

   

7. The potential of somatostatin receptor 2 as a novel therapeutic target in salivary gland malignant tumors

   • Amichay Meirovitz
   • Karny Shouchane-Blum
   • Jeffrey Weinberger

   Original Article – Cancer Research 17 February 2021 Pages: 1335 - 1340

   

8. Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling

   • Yutaka Endo
   • Mao Fujimoto
   • Eri Arai

   Original Article – Cancer Research Open access 26 February 2021 Pages: 1341 - 1354

   

9. Using ultrasound-targeted microbubble destruction to enhance radiotherapy of glioblastoma

   • Chanjuan Peng
   • Yong Wu
   • Chen Yang

   Original Article – Cancer Research Open access 06 February 2021 Pages: 1355 - 1363

   

10. Personalized oncology and BRAF^K601N melanoma: model development, drug discovery, and clinical correlation

    • Brian A. Keller
    • Brian J. Laight
    • John C. Bell

    Original Article – Cancer Research 08 February 2021 Pages: 1365 - 1378

    

11. Mycoplasma hyorhinis infection promotes tyrosine kinase inhibitor (TKI) resistance in lung adenocarcinoma patients

    • Yueyu Dai
    • Fangyuan Zhong
    • Weiguo Hu

    Original Article – Cancer Research 06 February 2021 Pages: 1379 - 1388

    

12. Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases

    • Zenan Lin
    • Daniela Süsskind

    Original Article – Cancer Research 04 March 2021 Pages: 1389 - 1405

    

13. Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study

    • Manuela Limam
    • Katarina Luise Matthes
    • Sabine Rohrmann

    Original Article – Cancer Research Open access 04 March 2021 Pages: 1407 - 1419

    

14. Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer

    • L. C. Hanker
    • A. El-Balat
    • F. Hoellen

    Original Article – Cancer Research Open access 03 March 2021 Pages: 1421 - 1430

    

15. Clinical application of circulating tumor DNA in breast cancer

    • Jeffrey Chun Hin Chan
    • James Chung Hang Chow
    • William C. Cho

    Review – Clinical Oncology 24 March 2021 Pages: 1431 - 1442

    

16. Diet-related interventions for cancer-associated cachexia

    • Alan J. Kim
    • David S. Hong
    • Goldy C. George

    Review – Clinical Oncology 15 March 2021 Pages: 1443 - 1450

17. Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcoma

    • Takeshi Iwasaki
    • Kenichi Kohashi
    • Yoshinao Oda

    Original Article – Clinical Oncology 20 September 2020 Pages: 1451 - 1463

    

18. Correction to: Association of PD-L1 and IDO1 expression with JAK–STAT pathway activation in soft-tissue leiomyosarcoma

    • Takeshi Iwasaki
    • Kenichi Kohashi
    • Yoshinao Oda

    Correction 24 November 2020 Pages: 1465 - 1467

19. Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma

    • Shenmiao Yang
    • Dong Dong
    • Xiaojun Huang

    Original Article – Clinical Oncology 19 October 2020 Pages: 1469 - 1479

20. Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety

    • Lukas Schrickel
    • Florian H. Heidel
    • For the German Study Group MPN, GSG-MPN

    Original Article – Clinical Oncology 02 November 2020 Pages: 1481 - 1491

21. The previously common post-kidney transplant Kaposi sarcoma has become non-existent for a decade: an Egyptian experience

    • Ahmed Farouk Donia
    • Mohammed Ashraf Fouda
    • Bedeir Ali-El-Dein

    Original Article – Clinical Oncology 01 November 2020 Pages: 1493 - 1498

22. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor

    • Yuichi Shibui
    • Kenichi Kohashi
    • Yoshinao Oda

    Original Article – Clinical Oncology 21 November 2020 Pages: 1499 - 1518

    

23. Feasibility of limited resection for peripheral small-sized non-small cell lung cancer: a retrospective single-center-based study

    • Masato Aragaki
    • Yasuhiro Hida
    • Satoru Wakasa

    Original Article – Clinical Oncology 05 November 2020 Pages: 1519 - 1527

    

24. Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine as first-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma: a randomized study

    • Yuan Zong
    • Jiajia Yuan
    • Jun Zhou

    Original Article – Clinical Oncology 15 November 2020 Pages: 1529 - 1536

    

25. Analysis of failed therapy evaluations in radioembolization of primary and secondary liver cancers

    • Max Masthoff
    • Philipp Schindler
    • Moritz Wildgruber

    Original Article – Clinical Oncology Open access 06 November 2020 Pages: 1537 - 1545

26. Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China

    • Qiang Zheng
    • Yan Huang
    • Yuan Li

    Original Article – Clinical Oncology 16 November 2020 Pages: 1547 - 1556

    

27. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling

    • Yan Du
    • Zechang Xin
    • Jie Yao

    Original Article – Clinical Oncology 02 January 2021 Pages: 1557 - 1564

    

28. Comment on article by Christina Puhr Hannah et al.: Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma

    • Xiao Yang
    • Chang-sheng Xie

    Letter to the Editor 27 February 2021 Pages: 1565 - 1565

29. Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma

    • Hannah Christina Puhr
    • Ayseguel Ilhan-Mutlu

    Letter to the Editor 27 February 2021 Pages: 1567 - 1568